2017

Vehlow, A., Klapproth, E., Storch, K., Dickreuter, E., Seifert, M., Dietrich, A., Bütof, R., Temme, A., Cordes, N. (2016). β1 integrin and JNK dependence of glioblastoma stem-like cell radiochemoresistance and invasion. Oncotarget 2017 Jul25; 8(30): 49224-49237.

Zschaeck, S., Hofheinz, F., Zöphel, K., Bütof, R., Jentsch, C., Schmollack, J., Löck, S., Kotzerke, J., Barreton, G., Weitz, J., Baumann, M., Krause, M. (2017). PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial. Eur J Nucl Med Mol Imaging 2017 doi: 10.1007/s00259-017-3742-0. [Epub ahead of print]

2016

Hofheinz, F., Bütof, R., Apostolova, I., Zöphel, K., Steffen, I.G., Amthauer, H., Kotzerke, J., Baumann, M., van den Hoff, J. (2015). An investigation of the relation between tumor-to-liver ratio (TLR) and tumor-to-blood standard uptake ratio (SUR) in oncological FDG PET. EJNMMI Res. 2016 Dec;6(1):19.

Tillner, F., Thute, P., Löck, S., Dietrich, A., Fursov, A., Haase, R., Lukas, M., Rimarzig, B., Sobiella, M., Krause, M., Baumann, M., Bütof, R. and Enghardt, W. (2015). Precise image-guided irradiation of small animals: a flexible non-profit platform. Phys Med Biol. 2016 Apr 21;61(8):3084-108.

Zschaeck, S., Simon, M., Löck, S., Troost, EG., Stützer, K., Wohlfahrt, P., Appold, S., Makocki, S., Bütof, R., Richter, C., Baumann, M., Krause, M. (2016). PRONTOX - proton therapy to reduce acute normal tissue toxicity in locally advanced non-small-cell lung carcinomas (NSCLC): study protocol for a randomised controlled trial. Trials 2016 Nov15,
17 (1):543.

2015

Bütof R, Krause M (2015) Tumorvolumenbestimmung ‒ Anforderungen der Strahlentherapie an die moderne radiologische Bildgebung. Der Onkologe 21: 382–387

Bütof, R., Hofheinz, F., Zöphel, K., Stadelmann, T., Schmollack, J., Jentsch, C., Löck, S., Kotzerke, J., Baumann, M., van den Hoff, J. (2015). Prognostic value of pretherapeutic tumor-to-blood standard uptake ratio (SUR) in patients with esophageal carcinoma. J Nucl Med. 2015 Aug;56(8):1150-6.

2014

Tillner F, Thute P, Bütof R, Krause M, Rolle A Höffken G, Krause M, Enghardt W (2014) Preclinical research in small animals using radiotherapy technology - a bidirectional translational approach. Z Med Phys 24: 335–351

Bütof R, Kirchner K, Appold S, Löck S, Rolle A, Höffken G, Krause M, Baumann M (2014) Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlenther Onkol 190: 263–269

2013

Bütof R, Dubrovska A, Baumann M (2013) Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol 108: 388–396

Bütof R, Baumann M (2013) Time in radiation oncology – Keep it short! Radiother Oncol 106: 271–275

2011

Gurtner K, Deuse Y, Bütof R, Schaal K, Eicheler W, Oertel R, Grenman R, Thames H, Yaromina A, Baumann M, Krause M (2011) Diverse effects of combined radio-therapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression. Radiother Oncol 99: 323–330